Approval · Notice of Compliance 27492 · 2022
ONE-ALPHA: Notice of Compliance 27492
Issued January 29, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27492
- Date
- January 29, 2022
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Change in Product Ownership; Change in the layout and content of the packaging material; Converting the Product Monograph to the 2020 format.
Products in this notice
Medicinal ingredients
- ALFACALCIDOL 0.25 MCG per CAP
- ALFACALCIDOL 1 MCG per CAP
- ALFACALCIDOL 2 MCG per ML